{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"306"},{"groupId":"OG001","value":"307"}],"units":"Participants"}],"groups":[{"description":"Patients receive levofloxacin PO or IV over 60-90 minutes once or twice daily beginning on day 3 during 2 consecutive courses of chemotherapy or beginning on day -2 during HSCT and continuing until blood counts recover.\n\nlevofloxacin: Given PO or IV","id":"OG000","title":"Arm I (Levofloxacin)"},{"description":"Patients receive established standard of care and receive chemotherapy or HSCT as patients in Arm I.","id":"OG001","title":"Arm II (Standard of Care)"}],"paramType":"NUMBER","populationDescription":"Evaluable patients combined from both AL and HSCT cohorts were reported. Ineligible and withdrew of Consent prior to Tx were excluded.","reportingStatus":"POSTED","timeFrame":"Up to 60 days after enrollment or receiving levofloxacin","title":"Comparison of the Percentage of Patients That Died Due to Bacterial Infection Between Arms","type":"SECONDARY","unitOfMeasure":"Percentage of patients"}